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ABSTRACT: The purpose of the current review is to summarize data regarding hereditary myelopathies in dogs. 
Canine degenerative myelopathy (DM) is a progressive disease prevalent in senior (≥8 years old), large breed-dogs, 
predominating in German shepherd dog. Neurolocalization indicates a thoracolumbar, upper motor neuron, lesion; it 
can progress to the thoracic limbs and later to lower motor neurons of all limbs resembling human amyotrophic lateral 
sclerosis (ALS). Tentative diagnosis is based on ruling out other progressive myelopathies. Clinical similarities be-
tween ALS and DM made superoxide dismutase 1 gene (SOD1) a viable candidate gene as an etiopathogenic factor. 
Α E40K missense mutation of the SOD1 has been linked to DM. A genetic test for DM exists, which will aid breeding 
programs to eliminate the disease. Exercise and physiotherapy are important to slow the progression of DM. Long-term 
prognosis is poor as dogs become non-ambulatory within 4-6 months from the time of diagnosis. Dystrophic myelopa-
thies include Afgan hound myelopathy/hereditary necrotizing myelopathy in Kooikerhondje dogs, leukoencephalomy-
elopathy and neuroaxonal dystrophy in Rottweilers and spongiform leukoencephalomyelopathy. A similar myelopathy 
is Jack Russell and Fox terrier hereditary ataxia. Their etiology is suspected to be hereditary and they appear at a young 
age. They are diagnosed solely postmortem with histopathological examination. There is no etiologic treatment and 
the prognosis is poor except for Rottweiler neuroaxonal dystrophy and Jack Russel ataxia due to the extremely slow 
progression of symptoms. Syringomyelia is characterized by the formation of fluid filled cavities within the spinal cord 
and outside the central canal that may communicate with the central canal and it is caused mainly due to Chari-like 
malformation (CLM). The most important clinical sign is neuropathic pain and is localized in the cervical region of the 
spinal cord. Progression of the disease varies, there are severe disabilities due to pain or it can be an incidental finding. 
CT and MRI are the preferable ways to detect the lesions. For CLM, therapy includes surgical and medical manage-
ment. Drugs can be divided into analgesics (non-steroidal anti-inflammatory, gabapentin, pregabalin, tramadol), drugs 
reducing cerebrospinal fluid (CSF) production (omeprazole, acetazolamide, furosemide) and corticosteroids. Medical 
therapy diminishes the severity of clinical signs but never succeeds full resolution.
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INTRODUCTION
The etiology of myelopathies is multifactorial. Clinical signs depend on the location, size, and 
the rate of lesion development (Dewey and da Costa, 
2016). The current review focuses on the most im-
portant hereditary myelopathies in dogs. Summarized 
data of the hereditary myelopathies are found in Ta-
bles 1 and 2. 
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Table 2. Major clinicopathological findings of the hereditary myelopathies
Hereditary myelopathies Anatomical region affected Clinicopathological findings
Degenerative myelopathy T3-L3 spinal cord segments Dorsal portion of lateral and dorsal funiculi 
of the white matter:
axon degeneration, myelin loss
Dystrophic myelopathies
Afgan hound myelopathy C6-T2, T3-L3 spinal cord Dorsal and ventro-medial white matter: 
myelin loss, vessel proliferation
Rottweiler leukoencephalopathy Cervical spinal cord
Brainstem/Cerebellar
Dorsolateral funiculi of the white matter: 
demyelinating lesions
Demyelinating lesions
Rottweiler neuroaxonal dystrophy Cervical spinal cord Dorsal horn grey matter: dystrophic axons
Spongiform leukoencephalopathy Cervical spinal cord, brain Spongiform change of the white matter, 
diminished myelin content, absence of 
microgliosis, Rosenthal fibers (astrocytic 
inclusion bodies)
Jack Russel/Fox-terrier ataxia Cervical spinal cord Dorsal and ventral funiculi
Syringomyelia (Hydromyelia) Cervical spinal cord Fluid-filled dilatation +/- communication 
with spinal canal
http://epublishing.ekt.gr | e-Publisher: EKT | Downloaded at 23/08/2021 04:49:40 |
J HELLENIC VET MED SOC 2021, 72(1)
ΠΕΚΕ 2021, 72(1)
2585R.D. BAKA, Z.S. POLIZOPOULOU
DEGENERATIVE MYELOPATHY (DM)
Degenerative myelopathy (DM) in dogs was first 
described by Averill in 1973 as a specific degenera-
tive spinal cord disease (Kathmann et al 2006; Grang-
er and Neeves, 2015).
Canine degenerative myelopathy is a slow, pro-
gressive neurodegenerative disease prevalent in sev-
eral dog breeds (Griffiths and Duncan, 1975; Barclay 
and Haines, 1994; Coates et al. 2007; Awano et al. 
2009; Holder et al. 2014; March et al. 2009; Miller 
et al. 2009). It has been recognized for > 35 years as 
a spontaneously occurring, adult-onset spinal cord 
disorder (Awano et al. 2009). Early neuroanatomical 
localization indicates a lesion between the 3rd thorac-
ic (T3) and the 3rd lumbar (L3) spinal cord segments 
(Kathmann et al. 2006; Coates et al. 2007; Awano et 
al. 2009; Miller et al. 2009) and in lumbosacral spi-
nal cord (Kathmannet al. 2006). Initially the disease 
is thought to be breed-specific to German Shepherds 
(GSD), thus named German shepherd myelopathy 
(Braund and Vandevelde, 1978; Longhofer et al. 
1990; Barclay and Haines, 1994; Coates et al. 2007; 
Awano et al. 2009; March et al. 2009; Holder et al. 
2014). However, other large breeds, including Old 
English sheepdog, Belgian shepherd, Collie, Giant 
Schnauzer, Labrador retriever, Borzoi, Soft-coated 
Wheaten terrier, Mastiff (Kathmann et al. 2006), Rho-
desian Ridgeback, Boxer, Chesapeake Bay Retriever 
(Long et al. 2009; Granger and Neeves, 2015), Hov-
awart, Bernese Mountain dog, Kuvasz (Kathmann 
et al. 2006), Pug and Cavalier King Charles spaniel 
(Granger and Neeves, 2015), along with mixed-breed 
dogs have been reported to develop the disease. Pem-
broke Welsh Corgi (PWC) is a breed commonly af-
fected by DM (Coates et al. 2007; Long et al. 2009; 
Miller et al. 2009; Granger and Neeves, 2015). DM 
is confirmed histologically in 3 closely related Sibe-
rian husky dogs, suggesting that hereditary factors 
may be involved in the pathogenesis (Bichsel et al. 
1983). Interestingly, there is a feline case report with 
a presumed histopathological diagnosis of degenera-
tive myelopathy due to the histopathological similar-
ities identified in the thoracolumbar segments and the 
cause of the lesion that is not apparent (Mesfin et al. 
1980).
There is no sex predilection in DM (Kathmann 
et al. 2006; Awano et al. 2009; Granger and Neeves, 
2015), although in affecting PWC there is a predom-
inance of females (Coates et al. 2007). Most dogs 
are at least 8 years of age before the onset of clinical 
signs (Griffiths and Duncan, 1975; Kathmann et al. 
2006; Awano et al. 2009; Crisp et al. 2014; Holder 
et al. 2014; Granger and Neeves, 2015), but young 
dogs can be affected as well (Coates et al. 2007; Po-
lizopoulou et al. 2008). Interestingly, there are re-
ported cases in 2 juvenile German Shepherds (6 and 
7 months old) that present symptoms compatible to 
DM, which is confirmed histologically (Longhofer 
et al. 1990). On the contrary, in DM-affected PWC, 
there is a slightly older age distribution (median age 
11 years) compared with previous studies (Coates et 
al. 2007; March et al. 2009). The initial clinical sign is 
a spastic and general proprioceptive ataxia and pare-
sis of the pelvic limbs (Longhofer et al. 1990; Barclay 
and Haines, 1994; Kathmann et al. 2006; Awano et al. 
2009; March et al. 2009; Crisp et al. 2014; Granger 
and Neeves, 2015). The asymmetric/symmetric weak-
ness frequently progresses to paraplegia (Polizopou-
lou et al. 2008; Awano et al. 2009). At this stage of the 
disease, the preservation of spinal reflexes indicate an 
upper motor neuron paresis (Kathmann et al. 2006; 
Awano et al. 2009) although the patellar reflex can be 
decreased or abolished because of lesions in the dor-
sal nerve root ganglia (Miller et al. 2009). Pain sen-
sation, bladder control and the panniculus reflex are 
normal (Griffiths and Duncan, 1975). Hyporeflexia of 
the myotatic and withdrawal reflexes occur in the ad-
vanced disease stage (Kathmann et al. 2006; Awano et 
al. 2009). In dogs that are not euthanized, the disease 
progresses and thoracic limbs may be affected (Bar-
clay and Haines, 1994; Awano et al. 2009; Miller et al. 
2009; Crisp et al. 2014). In advanced DM cases, dogs 
may also exhibit signs of lower motor neuron disease, 
including flaccid tetraparesis, generalized muscle at-
rophy and hyporeflexia of all limbs (Kathmann et al. 
2006; Awano et al. 2009; Miller et al. 2009). The dis-
ease duration can exceed 3 years however; most dog 
owners elect euthanasia within 6 months to a year of 
diagnosis and after they become paraplegic (Awano et 
al. 2009). Clinical progression of DM in PWC is sim-
ilar to that of DM in GSD and other described breeds, 
however, it is characterized by a longer duration (19 
months versus 6 months) (Coates et al. 2007). Many 
affected dogs may survive with supportive nursing 
care until respiratory failure develops, which has been 
reported to occur 3 years or later after the disease on-
set (Nakamae et al. 2015).
Tentative antemortem diagnosis is based upon rul-
ing out other diseases causing progressive myelopa-
thy (Coates et al. 2007; Granger and Neeves, 2015). 
Common differentials include spinal cord compres-
http://epublishing.ekt.gr | e-Publisher: EKT | Downloaded at 23/08/2021 04:49:40 |
J HELLENIC VET MED SOC 2021, 72(1)
ΠΕΚΕ 2021, 72(1)
2586 R.D. BAKA, Z.S. POLIZOPOULOU
sion, inflammatory disease and neoplasia (Griffiths 
and Duncan, 1975; Jones et al. 2005; Coates et al. 
2007). Hip dysplasia and lumbosacral stenosis can 
often be confused with DM, but the neurologic defi-
cits are different if a careful examination is performed 
(Griffiths and Duncan, 1975; Coates et al. 2007). It 
is worth remembering that hip dysplasia can often 
co-exist with DM and exaggerate the signs seen in 
the latter disease (Griffiths and Duncan, 1975). Ini-
tial tentative diagnosis is based on signalment (old-
er large-breed dogs) and onset of clinical sigs (slow 
progression) (Kathmann et al. 2006). The proposed 
diagnostic investigation includes advanced diagnos-
tic imaging techniques (computed tomography-CT, 
magnetic resonance imaging-MRI), along with ce-
rebrospinal fluid (CSF) analysis (Jones et al. 2005; 
Kathmann et al. 2006; Coates et al. 2007). Results of 
CSF analysis are usually unremarkable although oc-
casionally increased protein concentration is noted, 
especially when samples are collected via a lumbar 
tap (Kathmann et al. 2006). Morphologic character-
istics such as spinal stenosis, focal attenuation of the 
subarachnoid space, spinal cord deformity, small spi-
nal cord and paraspinal muscle atrophy are common 
in DM dogs detected via computed tomography com-
bined with myelography (Jones et al. 2005). 
Clinical similarities between amyotrophic lateral 
sclerosis (ALS) and DM lead to the investigation of 
superoxide dismutase 1 (SOD1), a gene potentially 
involved in DM pathogenesis (Awano et al. 2009; 
Holder et al. 2014; Ivansson et al. 2016). In humans, 
ALS is a disease typically seen between the ages of 45 
and 60, where degeneration of upper and lower motor 
neurons culminates in paralysis and death (Holder et 
al. 2014). Studies suggest SOD1 activity is unaffected 
by the presence of SOD1 mutations. Instead, proteins 
encoded by the mutation version of the gene demon-
strate an increased propensity to form aggregates. The 
relationship of this finding to the pathogenesis of neu-
ronal dysfunction seen in ALS and DM is to be elu-
cidated (Holder et al. 2014). However, while SOD1 
mutation homozygosis is a predisposing risk fac-
tor, some affected animals do not have the mutation 
(Awano et al. 2009; Chang et al. 2013). Furthermore, 
carrier dogs might not develop the disease (Awano et 
al. 2009; Chang et al. 2013).
There is a study including at risk-PWC dogs ho-
mozygous for the SOD1 risk allele, detecting genetic 
modifier loci that are differentiated between dogs that 
developed the disease early and dogs that did not de-
velop the disease even at an advanced age (Ivansson 
et al. 2016). The study results suggest that the mu-
tant SOD1 proteins accumulate in reactive astrocytes 
during the early phase of DM pathology, which may 
contribute to subclinical neurodegeneration (Ko-
batake et al. 2016).
Recently, a novel missense mutation, associated 
with DM, has been described in the Bernese mountain 
dog (T18S) (Capucchio et al. 2014; Crisp et al. 2014). 
Both E40K and T18S mutations in cSOD1 are not loss 
of function mutations, but form enzymatically active 
dimers that are prone to aggregation in vitro (Crisp et 
al. 2014). A genetic test for DM has been developed 
and is expected to aid in planning breeding programs 
designed to slowly eliminate DM (Long et al. 2009; 
Holder et al. 2014). Dogs showing consistent clini-
cal signs and being homozygous for the mutation, are 
raising the index of suspicion of DM whereas those 
with heterozygous or homozygous wild-type gen-
otypes are considered more likely to be affected by 
other disease processes (Holder et al. 2014).
A polyclonal antibody against cSOD1 is generated 
to further characterize the mutant SOD1 protein and 
its involvement in DM pathogenesis (Nakamae et al. 
2015). Definite diagnosis of DM is determined post-
mortem by histopathological examination of the spi-
nal cord (Coates et al. 2007; March et al. 2009). Neu-
romuscular histopathological findings include axon 
loss, which begins in the thoracolumbar spinal cord 
and later may involve the cervical and lumbar seg-
ments (Barclay and Haines, 1994; Coates et al. 2007; 
March et al. 2009). Lesions are restricted to the white 
matter (Barclay and Haines, 1994) and described as 
discontinuous, bilateral and asymmetric (Longhofer 
et al. 1990; Coates et al. 2007; March et al. 2009). All 
white matter funiculi are affected but a predominance 
of lesions in the dorsal portion of the lateral funiculus 
and dorsal funiculus have been reported (March et al. 
2009; Miller et al. 2009). The degenerative changes in-
volve both the axons and the myelin sheaths (Griffiths 
and Duncan, 1975; March et al. 2009) with dilation 
of the myelin sheath, axonal swelling and concurrent 
fragmentation and phagocytosis of axonal and myelin 
debris (March et al. 2009). Both motor and sensory 
tracks are affected (Johnston et al. 2000). They oc-
cur at the distal portions of the fiber tracks (Griffiths 
and Duncan, 1975; Johnston et al. 2000). In the dor-
sal columns, the rostral portion is affected (Griffiths 
and Duncan, 1975). Histologically, there are vacuolar 
spaces which represent lost myelin and axonal degen-
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eration which appears as large eosinophilic circular 
granular bodies in sections stained with hematoxylin 
and eosin (Barclay and Haines, 1994). Together, these 
result in a spongy appearance of the white matter his-
tologically (Barclay and Haines, 1994). 
Studying the brain of DM-affected dogs reveals 
neuronal degeneration and loss in the red, lateral ves-
tibular and dentate nuclei, changes that may be related 
to the origin of the damage and subsequent Wallerian 
degeneration (Kathmann et al. 2006).
Affected dogs present lesions in the posterior and 
lateral columns (Awano et al. 2009). In all DM af-
fected dogs, the surviving spinal cord neurons con-
tain cytoplasmic inclusions which are stained with 
anti-SOD1 antibodies, appearing as well-defined dark 
clumps immunohistologically (Awano et al. 2009; 
Granger and Neeves, 2015). Homozygosity for the A 
allele is associated with DM in 5 dog breeds: Pem-
broke Welsh Corgi, Boxer, Rhodesian ridgeback, Ger-
man shepherd and Chesapeake Bay retriever (Awano 
et al. 2009). In contrast, homozygosity for G allele 
and heterozygotes, no staining or diffuse light stain-
ing similar to the background staining is found in cells 
of the spinal cords (Awano et al. 2009). 
Several authors suggest that exercise and physio-
therapy are important to slow the progression of DM 
(Kathmann et al. 2006; Granger and Neeves, 2015) 
by virtue of optimizing muscular tone and blood cir-
culation. Walking or swimming should be done on 
a daily or every other day schedule (Polizopoulou 
et al. 2008). In a study performed in DM-affected 
dogs, daily, controlled physiotherapy prolongs sur-
vival time to an average of 255 days (Kathmann et 
al. 2006). A physiotherapy protocol can include daily 
gait exercise, massage, passive joint movement and 
hydrotherapy and it seems to be the most important 
factor in preserving ambulatory status in dogs with 
DM (Kathmann et al. 2006). Thus, even in dogs with 
severe neurological deficits at the time of diagnosis, 
physiotherapy may result in longer survival time even 
in comparison with dogs with minor neurological defi-
cits that do not receive physiotherapy (Kathmannet 
al. 2006).When the affected animals are left untreat-
ed, non-ambulatory paraplegia is usually established 
within 6 months after the initial diagnosis (Kathmann 
et al. 2006; Polizopoulou et al. 2008).
Long-term prognosis is poor (Coates et al. 2007). 
Dogs lose the ability to ambulate within 4-6 months 
from the time of diagnosis (Coates et al. 2007). Tho-
racic limb function and urinary and fecal continence 
usually are spared until end-stage disease (Coates et 
al. 2007).
DYSTROPHIC MYELOPATHIES
Afgan hound myelopathy/ Hereditary necrotizing 
myelopathy in Kooikerhondje dogs
This is a rapidly progressive myelopathy with an 
autosomal recessive mode of inheritance (Averill and 
Bronson, 1977). It appears in young (3-13 months 
old) Afgan hounds (Averill and Bronson, 1977; Dew-
ey and da Costa, 2016). Neuroanatomically, it is a 
C6-T2 or a T3-L3 myelopathy (Dewey and da Costa, 
2016). Affected dogs present symmetrical paraparesis 
and become paraplegic or even tetraparetic/tetraple-
gic within 1-3 weeks (Dewey and da Costa, 2016). 
It can affect the respiratory function lethally (Dewey 
and da Costa, 2016). Diagnostic tests are normal ex-
cept for CSF analysis that may reveal increased total 
protein concentration in some cases (Dewey and da 
Costa, 2016). Diagnosis is established postmortem 
with the histopathological examination of the spinal 
cord. Lesions include symmetrical vacuolization with 
extensive myelin loss and vessel proliferation in the 
dorsal and ventro-medial spinal cord of the white mat-
ter from caudal cervical to lower lumbar segments, 
bilaterally (Averill and Bronson, 1977; Cummings 
and de Lahunta, 1978). There is no treatment and the 
prognosis is poor (Dewey and da Costa, 2016). A sim-
ilar disorder, which is called, hereditary necrotizing 
myelopathy is reported in Kooikerhondje dogs (Man-
digers et al. 1993).
Rottweiler leukoencephalomyelopathy
Leukoencephalopathy (LEM) is a progressive, 
non-painful, central nervous system (CNS) white mat-
ter disorder characterized by abnormal myelin synthe-
sis and/or maintenance (Dewey and da Costa, 2016). 
Its etiology remains unknown although it is suspected 
to be an inherited disease (Wouda and van Nes, 1986; 
Dewey and da Costa, 2016). Leukoencephalopathy 
with brain stem and spinal cord involvement is a neu-
rodegenerative disease in humans with clinical fea-
tures and MRI findings similar to the histopathologi-
cal lesions of LEM in Rottweiler dogs (Hirschvogel et 
al. 2013). Leukoencephalopathy in humans is caused 
by mutations in the DARS2 gene, which encodes a 
mitochondrial aspartyl-tRNA synthetase (Hirschvo-
gel et al. 2013). Due to the phenotypic similarities be-
tween human leukoencephalomyelopathy with brain 
stem and cervical involvement and lactate elevation 
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(LBSL) patients and LEM-affected Rottweiler dogs, 
the DARS2 gene is investigated as a candidate for 
canine LEM in a case, but no mutation in the gene 
is found (Hirschvogel et al. 2013). More advanced 
DNA sequencing, such as the use of next-genera-
tion technologies for whole-exome or whole-genome 
resequencing, may enable the identification of the 
causative mutation of Rottweiler LEM (Hirschvogel 
et al. 2013). Young adult Rottweiler and Rottweiler 
crossbred dogs are most commonly affected (Gamble 
and Chrisman, 1984; Dewey and da Costa, 2016). The 
neuroanatomical localization of the disease is the cer-
vical spinal cord (Dewey and da Costa, 2016). Clin-
ical signs include progressive ataxia, proprioceptive 
deficits which are more prominent in the pelvic limbs 
while hypermetria is more pronounced in the thoracic 
limbs (Dewey and da Costa, 2016; Hirschvogel et al. 
2013). Tetraparesis worsens slowly over maximum a 
year (Dewey and da Costa, 2016). 
Diagnostic investigation involves signalment, his-
tory, clinical signs and MRI (Dewey and da Costa, 
2016). CSF analysis, including measurement of pro-
teins and total nucleated cells count (TNCC), CSF 
cytology and measurement of lactate concentrations 
in the CSF and serum are unremarkable (Yin et al. 
2001; Löbert, 2003). Radiological examination of the 
cervical region of the spinal cord is normal (Dewey 
and da Costa, 2016). MRI findings are extremely rare, 
they have been described in only one case, showing 
bilateral symmetrical hyper intensities in the region 
of both lateral funiculi on transverse T2-weighted 
images and isointense on T1-weighted plain images 
(Hirschvogel et al. 2013). Due to the lack of a genet-
ic test for this disorder, postmortem histopathologi-
cal examination is required to confirm the diagnosis 
(Hirschvogel et al. 2013). Symmetrical demyelinat-
ing lesions are seen in the spinal cord, especially in 
the cervical region, brain stem and cerebellum. De-
myelination is more prominent in the dorsolateral fu-
niculi of the cervical spinal cord and explains both 
paresis and ataxia, as the ascending proprioceptive 
tracts and descending upper motor neuron (UMN) 
tracts traverse this region (Wouda and van Nes, 1986; 
Slocombe et al. 1989; Christman, 1991). Despite the 
cerebellar involvement, these dogs typically do not 
exhibit symptoms of cerebellar dysfunction (Davies 
and Irwin, 2003; Dewey and da Costa, 2016). There 
is no effective treatment against leukoencephalomy-
elopathy and prognosis is poor (Dewey and da Cos-
ta, 2016). There have been no reports of LEM in the 
literature since 1989 (Slocombe et al. 1989), which 
could suggest a true decrease in incidence, a lack of 
information about the disease or exclusion of carrier 
animals from breeding (Davies and Irwin, 2003).
Rottweiler neuroaxonal dystrophy
Neuroaxonal dystrophy is a degenerative, inherit-
ed UMN disease that affects young adult Rottweiler 
dogs (Davies and Irwin, 2003). Clinical signs appear 
at a young age (<12 months old), earlier than in leu-
koencephalomyelopathy (Christman, 1992; Boersma 
et al. 1995). They include forelimb hypermetria, pro-
gressive sensory ataxia, proprioceptive dysfunction 
(Cork et al. 1983; Evans et al. 1988; Boersma et al. 
1995; Davies and Irwin, 2003). Cerebellovestibular 
signs (head tremor, nystagmus) develop later in the 
course of the disease however strength is maintained 
(Christman, 1992; Davies and Irwin, 2003). Neuro-
anatomically, neuroaxonal dystrophy affects the cer-
vical region of the spinal cord as in leukoencepha-
lomyelopathy, however, the cerebellovestibular signs 
(frequent in the former disease) are lacking (Cork et 
al. 1983). Cerebellar atrophy was observed in the au-
topsy of two cases (Cork et al. 1983).
Definite diagnosis is based on postmortem his-
topathological examination of the spinal cord. Dys-
trophic axons appear swollen, eosinophilic, homo-
geneous or granular and contain variable amount of 
ubiquitin-immunoreactive deposits (Moretto et al. 
1993). Characteristic axonal spheroids are most prom-
inent in the dorsal horn grey matter, the nucleus of the 
dorsal spinocerebellar tract, the vestibular nucleus, 
and the nucleus gracilis, the lateral cuneate and cu-
neate nuclei (Cork et al. 1983; Chrisman, 1992). This 
distribution of lesions explains the predominance of 
sensory abnormalities observed clinically. Ultrastruc-
turally, spheroids appear to be swellings of distal ax-
ons which are filled with accumulations of smooth 
membrane-bound vesicles, membranous lamellae, 
dense bodies, and other organelles (Cork et al. 1983). 
An inherited disorder of axonal transport is suspected 
as the underlying defect in this disorder (Cork et al. 
1983; Siso et al. 2001). Siso et al. (2001) mention the 
presence of abnormal expression and accumulation of 
proteins, which participate in the trafficking, docking 
and fusion of the synaptic vesicle to the plasma mem-
brane. Similar findings have been observed in isolat-
ed dystrophic axons of aged dogs, indicating severe 
disruption of axonal transport in dystrophic axons in 
canine neuroaxonal dystrophy (Siso et al. 2001). Neu-
ropathological changes are similar to those identified 
in human neuroaxonal dystrophy (Cork et al. 1983).
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There is no therapy for neuroaxonal dystrophy 
(Boersma et al. 1995). The short term prognosis is 
not as poor as in leukoencephalomyelopathy because 
the progression of the disease is very slow and the 
affected dogs can be acceptable pets for several years 
(Christman 1992; Boersma et al. 1995). 
Spongiform leukoencephalomyelopathy
It has been reported in young Dalmatians, Minia-
ture Poodles and Border Terriers (Martin-Vaquero et 
al. 2012). It is a rare disorder called fibrinoid leuko-
dystrophy, and is characterized by lesions in both the 
brain and the spinal cord. Even though the spinal cord 
is affected, the predominant clinical signs are gener-
alized tremors (Martin-Vaquero et al. 2012). Histo-
pathological findings include a spongiform change 
affecting the white matter of the brain and spinal cord 
with diminished myelin content and absence of micro-
gliosis (Martin-Vaquero et al. 2012). This diminished 
myelin staining can indicate disruption of normal 
function or diminished formation (Martin-Vaquero et 
al. 2012). A prominent histopathological finding is the 
detection of Rosenthal fibers, which are astrocytic in-
clusion bodies, located in the white matter of the brain 
and the cervical region of the spinal cord (Richardson 
et al. 1991). Their origin is not clear, but it is believed 
that they represent a primary astrocytic abnormality 
(Borrett and Becker, 1985). It is not yet known wheth-
er the astrocytic abnormality is due to a genetically 
inherited enzyme deficiency (Richardson et al. 1991).
There is no curative treatment, the disease pro-
gresses and the prognosis is poor (Dewey and da Cos-
ta, 2016).
JACK RUSSELL AND FOX-TERRIER 
ATAXIA
It is a rare, presumably inherited, progressively 
degenerative axonopathy that was first diagnosed in 
Jack Russell terriers and Smooth-coated Fox terriers 
in Sweden and England (Björck et al. 1957; Hartley, 
1973). As these dogs have common ancestry, affected 
dogs are suspected to have the same disease (Rohdin 
et al. 2015). However, segregation analysis indicated 
different mode of inheritance in the two dog breeds 
despite the similarities between the diseases (Björck 
et al. 1957; Hartley, 1973; Wessmann et al. 2004). It 
has also been described in Ibizan hounds and Parson 
Russell terriers. In the latter, a missense mutation in 
the CAPN1 gene is found and is strongly associated 
with a phenotypically similar inherited ataxia (For-
man et al. 2013). Additionally, another missense mu-
tation in the KCNJ10 gene is significantly associated 
with a similar ataxic neurological disease in 14 dogs 
belonging in the Russell group of terriers (Gilliam et 
al. 2014) and in ataxic Smooth-haired Fox Terriers 
and Toy Fox Terriers (Rodhin et al. 2015). Identifica-
tion of this gene in a homozygous state in ataxic dogs 
of different, albeit related, breeds support an earlier 
assertion that this mutation is causal for a neurode-
generative disease that is inherited in an autosomal 
recessive mode (Gilliam et al. 2014).
Clinical signs appear at a young age (2-9 months), 
and worsen progressively (Wessmann et al. 2004). 
They include symptoms of cervical myelopathy; pel-
vic limb ataxia that progresses to all four limbs atax-
ia, dysmetric gait and occasional intention tremor 
suggesting cerebellar dysfunction than myelopathy. 
However the involvement of the spinocerebellar tract 
of the cervical spinal cord is a possible explanation 
for these clinical signs (dysmetric spastic gait and in-
tention tremor). Rodhin et al. (2010) mention clini-
cal evidence of brain stem involvement (behavioral 
changes, bilateral decreased menace response), that 
is confirmed histopathologically. Wessmann et al. 
(2004) report seizures occurring simultaneously with 
ataxia while others develop respiratory distress. Ad-
ditionally, they find that the brain lesions are detected 
only in Jack Russell Terriers and not in Fox Terriers 
(Wessmann et al. 2004). 
The disease can be clinically diagnosed with a 
high certainty because of the breed, the age of clin-
ical onset and the nature of the typical clinical signs 
(Wessmann et al. 2004). Routine laboratory tests in 
blood and CSF in addition to radiological examina-
tion of the spinal cord are normal (Wessmann et al. 
2004). Abnormal brain stem auditory- evoked poten-
tials (BAEPs) are recorded in affected dogs and can 
support clinical diagnosis. Diagnosis is confirmed 
postmortem with histopathological examination of 
the affected region (Hartley, 1973). Lesions are char-
acterized by bilateral myelopathy (Hartley, 1973; 
Summers et al.1995), and more precisely in the dorsal 
and ventral funiculi of the cervical region of the spi-
nal cord (Summers et al.1995). Regarding the lesions, 
they are located in the central auditory pathways, the 
dorsal part of the lateral lemniscus, the ventromedial 
sulcus of the ventral funiculus and the trapezoid body 
(Hartley, 1973; Summers et al. 1995). Rarely, lesions 
are found in the spinal ganglia of the lumbar region or 
the cauda equina (Hartley, 1973).
There is no curative therapy for this disease. Al-
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though it is not lethal, most dogs are euthanized after 
their owner’s request in their 1st year of life (Hartley, 
1973). However some cases with mild gait abnormal-
ities have survived for years (Wessmann et al. 2004).
SYRINGOMYELIA (HYDROMYELIA)
Syringomyelia is a fluid- filled dilatation within 
the spinal cord that can or cannot communicate with 
the central canal and is usually not lined by ependy-
mal cells (Lee et al. 1985; Norman, 1987; Wisoff and 
Epstein, 1989; McClarty et al. 1990; Kirberger et al. 
1997; Churcher and Child, 2000). In the vast major-
ity of cases, syringomyelia is the result of Chari-like 
malformation (CLM) (Oldfield et al. 1994; Rusbridge 
et al. 2000). A lot of breeds have been identified to 
be at risk for Chiari-like malformation, however, the 
Cavalier King Charles Spaniel (CKCS) is the pre-
dominantly affected breed (McGrath, 1960; Geib and 
Bistner, 1967; Churcher and Child, 2000; Rusbridge 
and Knowler,2004). Furthermore, syringomyelia can 
be caused by other spinal cord or brain malformation, 
spinal cord trauma, inflammatory of neoplastic pro-
cesses that obstructs the normal flow of CSF, or idio-
pathic with no underlying etiology (Schmahl and Kai-
ser, 1984; Child et al. 1986; Cauzinille and Kornegay, 
1992; Kirberger et al. 1997; Rusbridge and Knowler, 
2004).
 Clinical signs in CKCS with CLM may appear 
between 6 months and 3 years of age (Rusbridge et 
al. 2006). Depending on the underlying etiology dogs 
may be presented at any age but those with more se-
verely clinical signs tend to be younger than 2 years 
old (Rusbridge and Knowler, 2004). The most import-
ant clinical sign in syringomyelia is neuropathic pain 
(Rusbridge et al. 2000; Todor et al. 2000; Nakamu-
ra et al. 2004). Although lesion localization may be 
difficult, it usually involves the cervical spinal cord 
(Rusbridge et al. 2006). In CLM, there is cervical 
hyperesthesia appearing clinically with persistent 
scratching of the neck and shoulder without skin 
contact (phantom scratching) (Churcher and Child, 
2000; Rusbridge et al. 2000). Scoliosis associated 
with syringomyelia has also been identified mostly 
in young animals (Fourneaux et al. 1973; Child et 
al. 1986; Chuma et al. 1997; Rusbridge et al. 2000). 
Scoliosis secondary to syringomyelia is the result of 
muscular imbalance due to paraspinal muscle atro-
phy (Tagaki et al. 2005). Progression of the disease 
varies (Rusbridge et al. 2006). In some dogs, there 
is only scratching with mild pain, and other neuro-
logical disorders (ataxia, paresis) appear slowly and 
progressively or never (Rusbridge et al. 2006). How-
ever other dogs are severely disabled due to pain that 
progressed within 6 months from the first symptom 
observed (Rusbridge et al. 2006). In others, syringo-
myelia is an incidental finding (Lu et al. 2003). 
The age of clinical onset varies, depending on the 
etiology of the disease, the different rate of fluid ac-
cumulation and the ensuing spinal cord damage and 
dysfunction (Rusbridge et al. 2006). However, signs 
of pain are not well correlated with the size of the 
syrinx, ie, humans or animals with wider or longer 
syrinxes are not necessarily in more pain than those 
with smaller syrinxes (Lu et al. 2003; Nakamura et 
al. 2004). On the other hand, there are other reports 
showing a relationship between the degree of pain 
and the width of the syrinx; dogs with larger syrinx-
es are in pain and dogs with smaller syrinxes are not 
in pain (Rusbridge et al. 2007). Furthermore, Rus-
bridge et al. (2007) examined not only the width of 
the syrinx but also the localized damage in the spinal 
cord, indicating that the asymmetry of the syrinx, is 
important in the pathogenesis of neuropathic pain. 
There have reported other neurological disorders such 
as thoracic limb weakness, muscle atrophy (ventral 
horn cell damage), pelvic limb ataxia and weakness, 
white matter damage with involvement of the lumbar 
spinal cord by the syrinx (Rusbridge et al. 2000). Hy-
drocephalus has also been reported in syringomyelia 
cases (Schmahl and Kaiser, 1984; Itoh et al.1996).
Diagnostic imaging and especially CT and MRI 
are the preferable way to detect the cavitary lesions 
(Kirberger et al. 1997; Churcher and Child, 2000; 
Rusbridge et al. 2000). Mid-sagittal images provide 
excellent definition of intramedullary cavitation and 
allow quantitative investigation of the malformation 
(Churcher and Child, 2000). Sometimes, myelogra-
phy can be helpful, when the contrast medium en-
ters the cavity within the spinal cord (Kirberger et al. 
1997). CSF analysis is usually normal however some-
times it reveals mild inflammation. It is important to 
perform CSF analysis in order to rule out other diseas-
es (Kirberger et al. 1997).
For Chiari-like malformation (CLM), therapy can 
be either surgical and/or medical. However, therapy 
of CLM is beyond the scope of this review and thus 
only therapy reflecting the elimination of symptoms 
due to syringomyelia is going to be discussed. 
Medical treatment includes analgesics, drugs that 
reduce CSF production and corticosteroids (Rus-
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bridge et al. 2006). In mild cases, pain can be con-
trolled with nonsteroidal anti-inflammatory drugs 
(Rusbridge et al. 2000). For the relief of scratching, or 
more severe cases, gabapentin (10 mg/kg b.w.,orally, 
TID) is useful in order to eliminate the neuropathic 
pain (Levendoglu et al. 2004). Pregabalin (2 mg/kg 
b.w., orally, BID), which is considered more effec-
tive than gabapentin, and tramadol (2-4 mg/kg b.w., 
orally,TID/QID) may also be administered. There 
are some reports on medications that decrease CSF 
flow and include omeprazole, acetazolamide, furose-
mide but, clinical data on their use and effectiveness 
are lacking (Lindvall-Axelsson et al. 1992; Itoh et al. 
1996; Javaheri et al. 1997; Churcher and Child, 2000). 
Regarding acetazolamide, long-term treatment has 
adverse effects like abdominal pain, weakness, lethar-
gy and thus it is contradicted for long-term use (Vogh, 
1980; Shinnar et al. 1985; Carrion et al. 2001). Cor-
ticosteroids are administered (0.5 mg/kg b.w., orally, 
BID), to decrease CSF production (Rusbridge et al. 
2000). Although corticosteroids may be effective in 
limiting signs and progression, most dogs require 
continuous therapy and develop adverse effects such 
as immunosuppression, weight gain and skin changes 
(Rusbridge et al. 2000). Medical therapy can diminish 
the severity of clinical signs but they never succeed 
full resolution (Rusbridge et al. 2000). Regarding sur-
gical therapy, syringotomy can improve clinical signs 
(Cauzinille and Kornegay, 1992; Churcher and Child, 
2000). In another report, they performed laminecto-
my combining with acetazolamide and the dog par-
tially ameliorated, without deteriorating 12 months 
post surgically (Itoh et al.1996).
Syringomyelia is usually presented with pain. The 
degree of pain is evaluated clinically and is not neces-
sarily compatible with the severity of the lesions. Pain 
management can be sufficient to improve pet’s quality 
of life in most of the cases.
CONCLUSIONS
• Degenerative myelopathy is a progressive my-
elopathy of the thoraco-lumbar spinal cord seg-
ments, commonly seen in old German shepherd 
dogs.
• Physiotherapy can prolong the ambulatory status 
of the DM-affected dogs.
• Afgan hound myelopathy, Rottweiler leukoen-
cephalopathy, Rottweler neuroaxonal dystrophy, 
Spongiform leukoencephalopathy and Jack-Rus-
sel/ Fox-terrier ataxia are non-painful, hereditary 
myelopathies affecting the cervical region of the 
spinal cord.
• Syringomyelia is commonly caused by Chiari-
like malformation (CLM).
• Syringomyelia can become painful depending on 
the length and the size of the intramedullary flu-
id-filled syrinx.
• Therapy for syringomyelia caused by CLM in-
cludes surgical and medical management.
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